MARKER THERAPEUTICS, INC. Public Float
MARKER THERAPEUTICS, INC. (MRKR) had Public Float of $17.31 million as of 2025-06-30, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-18
- 2025-06-30: Entity Public Float $17.31M.
- 2024-06-30: Entity Public Float $48.45M.
- 2023-06-30: Entity Public Float $23.10M.
- 2022-06-30: Entity Public Float $22.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $17.31M 10-K · filed 2026-03-18 |
| 2024-06-30 | $48.45M 10-K · filed 2025-03-31 |
| 2023-06-30 | $23.10M 10-K · filed 2024-03-26 |
| 2022-06-30 | $22.80M 10-K · filed 2023-03-22 |
| 2021-06-30 | $164.30M 10-K · filed 2022-03-17 |
| 2020-06-30 | $64.60M 10-K · filed 2021-03-09 |
| 2019-06-28 | $198.90M 10-K · filed 2020-03-12 |
| 2018-06-30 | $81.40M 10-K · filed 2019-03-15 |
| 2017-06-30 | $30.50M 10-K · filed 2018-03-23 |
| 2016-06-30 | $36.55M 10-K · filed 2017-03-14 |
| 2015-06-30 | $36.52M 10-K · filed 2016-04-14 |
| 2014-06-30 | $30.93M 10-K · filed 2015-04-15 |
| 2013-11-15 | $0.00 10-Q · filed 2013-11-19 |
| 2013-06-28 | $3.42M 10-K/A · filed 2014-04-17 |
| 2013-05-09 | $0.00 10-Q/A · filed 2013-08-19 |
| 2011-06-30 | $0.00 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |